Antihyperlipidemic and Antioxidant Effects of Ethanol Fraction of Sargassum angustifolium in Dexamethasone-Induced Dyslipidemic Rats

Document Type : Original paper


1 Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

2 Department of Pharmacology and Toxicology, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.


Background and objectives: Recent data propose the beneficial antihyperlipidemic effects of several marine brown alga belonging to the genus Sargassum. In the current study, the effects of ethanol fraction of Sargassum angustifolium were assessed on dexamethasone-induced dyslipidemia in rats. Methods: The fraction was prepared by maceration method and then using a reverse phase column chromatography. It was evaluated for total phenolic and salt contents. Seven groups of six male rats were used as the following: group 1 (normal control) received vehicle for 1 week; group 2 (Sargassum control) was treated only with 80 mg/kg S. angustifolium for one week; group 3 (dyslipidemic control) received dexamethasone (10 mg/kg/day, subcutaneously) for one week; groups 4-6 (test groups) received dexamethasone and were simultaneously treated orally with 20, 40 or 80 mg/kg S. angustifolium and group 7 (reference) received dexamethasone and atorvastatin (40 mg/kg, orally) for one week. At the end of experiment, fasting blood glucose, lipid markers and malondialdehyde levels were evaluated in serum specimens. Livers were weighed and processed for histopathological inspection. Results: The content of total phenolics was 87.21 ± 2.4 mg/g as gallic acid equivalent and salt as NaCl was 6.5 g/100 g. Treatment with S. angustifolium significantly decreased serum blood sugar, triglycerides, total cholesterol, low‑density lipoprotein-cholesterol and malondialdehyde levels and also alleviated steatotic changes in liver tissues compared to the dexamethasone-induced dyslipidemic control group. Conclusion: Findings of the current study revealed anti-hyperglycemic, hypolipidemic and anti-lipid proxidative properties of S. angustifolium ethanol fraction in an animal model of dyslipidemia.


Main Subjects

  • Shattat GF. A review article on hyperlipidemia: types, treatments and new drug targets. Biomed Pharmacol J. 2015; 7(1): 399–409.
  • Kobiyama K, Ley K. Atherosclerosis. Circ Res. 2018; 123(10): 1118–1120.
  • Yang RL, Shi YH, Hao G, Li W, Le GW. Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index. J Clin Biochem Nutr. 2008; 43(3): 154–158.
  • Wilkinson MJ, Laffin LJ, Davidson MH. Overcoming toxicity and side-effects of lipid-lowering therapies. Best Pract Res Clin Endocrinol Metab. 2014; 28(3): 439–452.
  • Kaur G, Meena C. Evaluation of anti-hyperlipidemic potential of combinatorial extract of curcumin, piperine and quercetin in Triton induced hyperlipidemia in rats. Sci Int. 2013; 1(3): 57–63.
  • Surhio MM, Wang Y, Xu P, Shah F, Li J, Ye M. Antihyperlipidemic and hepatoprotective properties of selenium modified polysaccharide from Lachnum Int J Biol Macromol. 2017; 99: 88–95.
  • Dhargalkar VK, Neelam P. Seaweed: promising plant of the Millennium. Sci Cult. 2005; 71(3-4): 60–66.
  • Kuda T, Taniguchi E, Nishizawa M, Araki Y. Fate of water-soluble polysaccharides in dried Chorda filum a brown alga during water washing. J Food Compos Anal. 2002; 15(1): 3–9.
  • Manilal A, Sujith S, Kiran GS, Selvin J, Shakir C, Gandhimathi R, Panikkar Biopotentials of seaweeds collected from southwest coast of India. J Mar Sci Technol. 2009; 17(1): 67–73.
  • Akbari V, Zafari S, Yegdaneh A. Anti-tuberculosis and cytotoxic evaluation of the seaweed Sargassum boveanum. Res Pharm Sci. 2018; 13(1): 30–37.
  • Tapia-Martinez J, Hernández-Cruz K, Franco-Colín M, Mateo-Cid LE, Mendoza-Gonzalez C, Blas-Valdivia V, Cano-Europa Safety evaluation and antiobesogenic effect of Sargassum liebmannii J. Agardh (Fucales: Phaeophyceae) in rodents. J Appl Phycol. 2019; 31(4): 2597–2607.
  • Mushollaeni W, Supartini N, Rusdiana E. Decreasing blood cholesterol levels in rats induced by alginate of Sargassum duplicatum and Turbinaria derived from Yogyakarta. Asian J Agric Food Sci. 2015; 3(4): 321–326.
  • Liu X, Sun Z, Zhang M, Meng X, Xia X, Yuan W, Xue F, Liu Antioxidant and antihyperlipidemic activities of polysaccharides from sea cucumber Apostichopus japonicus. Carbohydr Polym. 2012; 90(4): 1664–1670.
  • Holdt SL, Kraan S. Bioactive compounds in seaweed: functional food applications and legislation. J Appl Phycol. 2011; 23(3): 543–597.
  • Kokabi M, Yousefzadi M. Checklist of the marine macroalgae of Iran. Bot Mar. 2015; 58(4): 307–320.
  • The European Parliament and the Council of the European Union. Directive 2010/63/EU on the protection of animals used for scientific purposes. [Accessed 2021]. Available from:
  • Farvin KS, Surendraraj A, Al-Ghunaim A, Al-Yamani F. Chemical profile and antioxidant activities of 26 selected species of seaweeds from Kuwait coast. J Appl Phycol. 2019; 31(4): 2653–2668.
  • Ye Y, Sun J, Wang L, Zhu J, Cui W, Hou H, Zhang J, Zhou C, Yan X. Isolation and purification of fucoxanthin from brown seaweed Sargassum horneri using open ODS column chromatography and ethanol precipitation. Molecules. 2021; Article ID
  • Skoog DA. Fundamentals of analytical chemistry. 8th London: Thomson/Brooks/Cole, 2004.
  • Pragda SS, Kuppast I, Mankani K, Ramesh L. Evaluation of antihyperlipidemic activity of leaves of Portulaca oleracea against dexamethasone induced hyperlipidemia in rats. Int J Pharm Pharm Sci. 2012; 4(4): 279–283.
  • Mesripour A, Rabian N, Yegdaneh A. The effect of different partitions of seaweed Sargassum plagyophylum on depression behavior in mice model of despair. J Complement Integr Med. 2019; Article ID 31125315.
  • Momi S, Impagnatiello F, Guzzetta M, Caracchini R, Guglielmini G, Olivieri R, Monopoli A, Gresele NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Eur J Pharmacol. 2007; 570(1-3): 115–124.
  • Fairhead VA, Amsler CD, McClintock JB, Baker BJ. Variation in phlorotannin content within two species of brown macroalgae (Desmarestia anceps and menziesii) from the Western Antarctic Peninsula. Polar Biol. 2005; 28(9): 680–686.
  • Cherry P, O’Hara C, Magee PJ, McSorley EM, Allsopp PJ. Risks and benefits of consuming edible seaweeds. Nutr Rev. 2019; 77(5): 307–329.
  • Wang JC, Gray NE, Kuo T, Harris CA. Regulation of triglyceride metabolism by glucocorticoid receptor. Cell Biosci. 2012; 2(1): 1–9.
  • Du WW, Liu F, Shan SW, Ma XC, Gupta S, Jin T, Spaner D, Krylov SN, Zhang Y, Ling W, Yang Inhibition of dexamethasone-induced fatty liver development by reducing miR-17-5p levels. Mol Ther. 2015; 23(7): 1222–1233.
  • Wang M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Meta. 2005; 2(1): 1–4.
  • Ahmed HH, Abdalla MS, Eskander EF, Al-Khadragy MF, Massoud MN. Hypolipidemic influence of Sargassum subrepandum: mechanism of action. Eur Rev Med Pharmacol Sci. 2012; 16(S3): 112–120.
  • Yu Z, Shuai L, Li X, Duan D, Guo Y. Regulating effect of Sargassum fusiforme (Harv.) Setch. on the level of blood lipid in experimental rats with hyperlipidemia. Med Plant. 2013; 4(5): 54–56.
  • Kwon DH, Choi YH, Kim BW, Hwang HJ. Effects of ethanol extract of Sargassum horneri on adipocyte differentiation and adipogenesis in 3T3-L1 preadipocytes. J Life Sci. 2019; 29(2): 209–214.
  • Raghavendran HR, Sathivel A, Devaki T. Effect of Sargassum polycystum (Phaeophyceae)-sulphated polysaccharide extract against acetaminophen-induced hyperlipidemia during toxic hepatitis in experimental rats. Mol Cell Biochem. 2005; 276(1): 89–96.
  • Mehdinezhad N, Ghannadi A, Yegdaneh A. Phytochemical and biological evaluation of some Sargassum species from Persian Gulf. Res Pharm Sci. 2016; 11(3): 243–249.
  • Cunha L, Grenha A. Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications. Mar Drugs. 2016; 14(3): 1–41.
  • Preetha SP, Devaraj H. Role of sulphated polysaccharides from Sargassum wightii in the control of diet-induced hyperlipidemia and associated inflammatory complications in rats. Eur J Inflamm. 2010; 8(1): 23–30.
  • Kolsi RB, Salah HB, Jardak N, Chaaben R, Jribi I, El Feki A, Rebai T, Jamoussi K, Allouche N, Blecker C, Belghith H, Belghith Sulphated polysaccharide isolated from Sargassum vulgare: characterization and hypolipidemic effects. Carbohydr Polym. 2017; 170: 148–159.
  • Husni A, Purwanti D, Ustadi. Blood glucose level and lipid profile of streptozotocin-induced diabetes rats treated with sodium alginate from Sargassum crassifolium. J Biol Sci. 2016; 16(3): 58–64.
  • Husni A, Anggara FP, Isnansetyo A, Nugroho AE. Blood glucose level and lipid profile of streptozotozin-induced diabetic rats treated with Sargassum polystum Int J Pharma Clin Res. 2016; 8(8): 445–450.
  • André R, Pacheco R, Bourbon M, Serralheiro ML. Brown algae potential as a functional food against hypercholesterolemia. Foods. 2021; 10(2): 1–14.
  • Jackson ER, Kilroy C, Joslin DL, Schomaker SJ, Pruimboom-Brees I, Amacher DE. The early effects of short-term dexamethasone administration on hepatic and serum alanine aminotransferase in the rat. Drug Chem Toxicol. 2008; 31(4): 427–445.
  • Quintal-Novelo C, Rangel-Méndez J, Ortiz-Tello Á, Graniel-Sabido M, Vaca RP, Moo-Puc R. A Sargassum fluitans Borgesen ethanol extract exhibits a hepatoprotective effect in vivo in acute and chronic liver damage models. Biomed Res Int. 2018; Article ID 6921845.